VIVOLTA is a leader in the field of electrospun nanofiber-based medical devices, tissue engineering products, and drug delivery solutions. Utilizing its fully automated MediSpin® technology platform, production of VIVOLTA’s solutions is both reproducible and scalable. Importantly, the MediSpin® platform, protected by seven patent families, meets the guidelines described in the first ASTM standard for fiber-based medical scaffolds (F3510-21), which VIVOLTA co-authored.

Focus Areas

Tissue Engineering
Drug Delivery
Women’s Health